Find ways to donate to and support the Department of Molecular Microbiology and Immunology.
Diabetes and Autoimmmunity Research Fund
In autoimmune diseases such as type 1 diabetes, the immune system attacks the very cells it was designed to protect. Habib Zaghouani, PhD, and others at the University of Missouri are working on potential treatments that combine adult stem cells with a promising new drug with the potential to accelerate development of treatments for type 1 diabetes and to other autoimmune diseases.
Microbes and Human Health Research Fund
Some bacteria cause diseases, while others are critical for nutrition, immunity and control of cancer. MMI is dedicated to understanding and manipulating the microbes that shape human health, especially those of the human gut microbiome.
Muscular Dystrophy Research Fund
Duchenne Muscular Dystrophy (DMD) is a debilitating and progressive disease that currently has no cure and that causes loss of muscle functions and weakness. Dongsheng Duan, PhD, and others at the University of Missouri are developing gene therapies to fight DMD by restoring normal function to the diseased muscles.
New Frontiers in Life Sciences Fund
For many types of cancer, including pancreatic, brain, and ovarian cancer, treatment options are extremely limited and survival rates are low. The New Frontiers in Life Sciences Fund, under the direction of Dr. Paul de Figueiredo, supports research to develop safe, efficacious, and affordable interventions that can defeat currently intractable cancers.
Tumor Immunology, Onco-therapy and Vaccine Design Research Fund
We are developing new ways to help a patient’s immune system detect, treat, and prevent cancers. At the same time, we are applying our understanding of immunological memory to improve the design of vaccines against pathogens and cancer.
Viruses and Human Health Research Fund
MU researchers are investigating influenza virus, HIV, Ebola virus, HCV, and other deadly human viruses at the molecular and cellular level. At the same time, they are harnessing useful viruses to combat cancer and to develop gene therapies for genetic diseases.
